![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity to Present At Upcoming Conferences
March 03, 2009 12:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 3, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Well-Financed to Achieve 'I4 2012' Long-Term Goals; Announces 2008 Financial Results
February 09, 2009 16:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 9, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today reiterated its "I4 2012" goals and...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Announces Hedgehog Pathway Preclinical Data in Ovarian Cancer
February 09, 2009 14:45 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 9, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the presentation of...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Announces Conference Call Discussing Fourth Quarter 2008 Results
February 02, 2009 17:45 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Announces 2009 and Long-Term Goals, Building On 2008 Success
January 12, 2009 06:00 ET
|
Infinity Pharmaceuticals, Inc.
Begins 2009 With Four Years of Capital, Three Clinical Candidates
in Development, Two New INDs, and One Pivotal Trial
Introduces "I4 2012" Long-Term Goals
CAMBRIDGE,...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Announces Completion of Second Equity Investment by Purdue
January 08, 2009 08:03 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 8, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced that its shareholders have voted...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity to Present At JP Morgan Healthcare Conference
January 06, 2009 08:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 6, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman,...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Reacquires Worldwide Rights to Its Hsp90 Inhibitor Program
December 11, 2008 06:00 ET
|
Infinity Pharmaceuticals, Inc.
Infinity to Independently Develop Its Industry-Leading Hsp90 Program
Clinical Programs Continue to Advance On Schedule
CAMBRIDGE, Mass., Dec. 11, 2008 (GLOBE NEWSWIRE) -- Infinity...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity to Present At Piper Jaffray 20th Annual Health Care Conference
November 26, 2008 13:45 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 26, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins,...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Announces Global Strategic Alliance With Purdue Pharma and Mundipharma Encompassing Infinity's Early Clinical and Discovery Programs
November 20, 2008 06:00 ET
|
Infinity Pharmaceuticals, Inc.
Infinity Retains All U.S. Rights; Mundipharma Receives Ex-U.S.
Commercialization Rights to All Oncology Products Under Alliance
Infinity to Receive Up to $75 Million Equity...